Bristol Myers has acquired Nvidia's latest artificial intelligence computing system for drug research, according to reports.

Bristol Myers Squibb, the company behind the purchase, claims it is building the largest NVIDIA AI supercomputer in the pharmaceutical industry.

According to Bristol Myers Squibb, this makes it the third drugmaker in nine months to announce plans for the largest AI supercomputer in the life sciences sector.